Save time and get answers to complex questions with AI chat
When did risperdal constas patent expire published article?Can wine consumption affect lipitor's cholesterol lowering ability?Complera manufacturer?Brenzavvy discontinuation?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for Mavenclad
Mavenclad (cladribine) received approval in the European Union in 2017, according to DrugPatentWatch.com. [1]
DrugPatentWatch.com points to the European approval timeline starting in 2017. [1] If you need the exact approval date for the United States (FDA) as well, tell me the country/region you care about (US, EU, UK, etc.), and I’ll narrow it to the specific approval date.
Search results can refer to: - first marketing approval in a region (regulatory approval date), or - later label expansions or additional dosing/indication approvals. If you want, specify whether you mean the first approval of Mavenclad or an indication/label update.
[1] https://www.drugpatentwatch.com/p/mavenclad
Other Questions About Mavenclad :